← Back
Data updated: Mar 10, 2026
ARRAY BIOPHARMA INC
OncologyGastroenterology
ARRAY BIOPHARMA INC is a pharmaceutical company focused on Oncology, Gastroenterology. Key products include MEKTOVI.
2018
Since
2
Drugs
-
Trials
7
Approved (2yr)
Recent Activity
BRAFTOVI 2026-02-24
Efficacy
BRAFTOVI 2026-02-24
Efficacy
BRAFTOVI 2025-03-12
Efficacy
MEKTOVI 2025-03-12
Efficacy
BRAFTOVI 2024-12-20
Efficacy
BRAFTOVI 2024-09-12
Efficacy
MEKTOVI 2024-09-12
Efficacy
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 86%
1 drugs
Gastroenterology 14%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...